← Leaderboards
Giulio Francia
University Of Texas El Paso
$1,917,723
Attributed
$1,917,723
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $377.5K · FY2016–23$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,917,723 · 2
By mechanism
SC1$1,464,723 · 1
SC2$453,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas El Paso
Same institution · by research overlap
- Guadalupe Corral$393,912
Others in their field
Top investigators on “Tumor Growth”
- David Heimbrook · Leidos Biomedical Research, Inc.$146,387,105
- Israel David Goldman · Yeshiva University$49,502,983
- Candace S Johnson · University Of Pittsburgh At Pittsburgh$44,839,363
- C Kent Osborne · Baylor College Of Medicine$40,237,256
- Alan F Horwitz · University Of Virginia Charlottesville$39,846,480
- Douglas Yee · University Of Minnesota$38,475,268
Research focus
Tumor GrowthUnited StatesPaclitaxelTumorTranslatingResponseMalignant Breast NeoplasmChemotherapyNovel StrategiesNeoplastic CellPre-ClinicalCancer CellGrowthGemcitabineBreast Cancer CellInnovationCause Of DeathAntineoplastic AgentsCellsBreast Cancer ModelBreast Cancer PatientClinical TrialsPharmaceutical PreparationsWoman
Grant awards (7)
The role of breast cancer organ specific metastasis on the therapeutic impact of anti-cancer drugs$367,300
SC1 · FY2023 · GM · contact PI
The role of breast cancer organ specific metastasis on the therapeutic impact of anti-cancer drugs$377,500
SC1 · FY2022 · GM · contact PI
The role of breast cancer organ specific metastasis on the therapeutic impact of anti-cancer drugs$362,823
SC1 · FY2021 · GM · contact PI
The role of breast cancer organ specific metastasis on the therapeutic impact of anti-cancer drugs$357,100
SC1 · FY2020 · GM · contact PI
Paclitaxel Directed Drug Screening: A New Strategy to Identify Anti-Cancer Drugs$151,000
SC2 · FY2018 · CA · contact PI
Paclitaxel Directed Drug Screening: A New Strategy to Identify Anti-Cancer Drugs$151,000
SC2 · FY2017 · CA · contact PI
Paclitaxel Directed Drug Screening: A New Strategy to Identify Anti-Cancer Drugs$151,000
SC2 · FY2016 · CA · contact PI